New Phase 3 Studies for Nektar’s Rezpegaldesleukin Promise Hair Regrowth & Long‑Term Skin ReliefRead how Nektar’s rezpegaldesleukin is reshaping alopecia and atopic dermatitis treatment—and what it means for investors.NEKTAR THERAPEUTICS Health Care Pharmaceuticals, Biotechnology & Life Sciences AI generated 02/10/2026, 21:25 3 minutes to read